{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:40:49Z","timestamp":1792082449738,"version":"4.4.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008398","name":"Internationale Stichting Alzheimer Onderzoek","doi-asserted-by":"crossref","award":["07553"],"award-info":[{"award-number":["07553"]}],"id":[{"id":"10.13039\/501100008398","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neuropharm.2012.06.048","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T03:21:53Z","timestamp":1341458513000},"page":"124-136","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe\/PS1dE9 mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Annerieke S.R.","family":"Sierksma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Sydlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Rostamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry W.M.","family":"Steinbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.A.","family":"van den Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Prickaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.06.048_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neurobiolaging.2005.05.009","article-title":"Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice","volume":"27","author":"Ambree","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-4159.2007.04704.x","article-title":"High intracellular concentrations of amyloid-beta block nuclear translocation of phosphorylated CREB","volume":"103","author":"Arvanitis","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1161\/CIRCRESAHA.110.233080","article-title":"Endothelial nitric oxide modulates expression and processing of amyloid precursor protein","volume":"107","author":"Austin","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib4","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1073\/pnas.95.25.15020","article-title":"Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory","volume":"95","author":"Barad","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A\u00a0synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2004.07.040","article-title":"Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance","volume":"47","author":"Boess","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.neurobiolaging.2004.06.010","article-title":"Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice","volume":"26","author":"Boncristiano","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11323-O","article-title":"Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease","volume":"187","author":"Bonkale","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib11","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/j.1476-5381.2011.01524.x","article-title":"GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses","volume":"164","author":"Bruno","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib12","doi-asserted-by":"crossref","first-page":"e27865","DOI":"10.1371\/journal.pone.0027865","article-title":"A\u00a0novel neurotrophic drug for cognitive enhancement and Alzheimer's disease","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-010-1943-3","article-title":"Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25\u201335 or Abeta1\u201340 peptide in rats","volume":"212","author":"Cheng","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbi.2010.11.016","article-title":"Caloric restriction attenuates age-related changes of DNA methyltransferase 3a in mouse hippocampus","volume":"25","author":"Chouliaras","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib15","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1523\/JNEUROSCI.2693-05.2005","article-title":"Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease","volume":"25","author":"Comery","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1471-4159.1992.tb11357.x","article-title":"Adenylyl cyclase activity in postmortem human brain: evidence of altered G protein mediation in Alzheimer's disease","volume":"58","author":"Cowburn","year":"1992","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1476-5381.2011.01517.x","article-title":"Sildenafil restores cognitive function without affecting beta-amyloid burden in a mouse model of Alzheimer's disease","volume":"164","author":"Cuadrado-Tejedor","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2008.02.108","article-title":"The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging","volume":"1216","author":"Domek-Lopacinska","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A\u00a0new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib21","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1126\/science.8389057","article-title":"Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons","volume":"260","author":"Frey","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","article-title":"Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease","volume":"24","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib23","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1523\/JNEUROSCI.5053-06.2007","article-title":"Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells","volume":"27","author":"Garzon","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib25","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archinte.163.13.1524","article-title":"An 18-year follow-up of overweight and risk of Alzheimer disease","volume":"163","author":"Gustafson","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF02246579","article-title":"Effects of purine analogues on spontaneous alternation in mice","volume":"123","author":"Hooper","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.neuropharm.2009.11.002","article-title":"Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice","volume":"58","author":"Hou","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","article-title":"Co-expression of multiple transgenes in mouse CNS: a comparison of strategies","volume":"17","author":"Jankowsky","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib30","first-page":"353","article-title":"Effect of sildenafil on anxiety in the plus-maze test in mice","volume":"56","author":"Kurt","year":"2004","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-6-17","article-title":"Differential regulation of BACE1 expression by oxidative and nitrosative signals","volume":"6","author":"Kwak","year":"2011","journal-title":"Mol. Neurodegener"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","article-title":"Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues","volume":"59","author":"Lakics","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/aps.2010.3","article-title":"The novel squamosamide derivative FLZ enhances BDNF\/TrkB\/CREB signaling and inhibits neuronal apoptosis in APP\/PS1 mice","volume":"31","author":"Li","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1037\/0735-7044.118.3.648","article-title":"Role of cyclic GMP in nitrous-oxide-induced anxiolytic-like behavior in the mouse light-dark exploration test","volume":"118","author":"Li","year":"2004","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib35","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/npp.2009.66","article-title":"Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus","volume":"34","author":"Li","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FBP.0b013e32833befe5","article-title":"Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression","volume":"21","author":"Liebenberg","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-012-9284-z","article-title":"Chronic treatment with the phosphodiesterase type 5 inhibitors sildenafil and tadalafil display anxiolytic effects in Flinders sensitive line rats","author":"Liebenberg","year":"2012","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbr.2010.12.030","article-title":"Treadmill exercise prevents decline in spatial learning and memory in APP\/PS1 transgenic mice through improvement of hippocampal long-term potentiation","volume":"218","author":"Liu","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib39","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1523\/JNEUROSCI.19-23-10250.1999","article-title":"Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus","volume":"19","author":"Lu","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/4525","article-title":"Cyclic AMP induces functional presynaptic boutons in hippocampal CA3-CA1 neuronal cultures","volume":"2","author":"Ma","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib41","doi-asserted-by":"crossref","first-page":"e26610","DOI":"10.1371\/journal.pone.0026610","article-title":"Subchronic peripheral neuregulin-1 increases ventral hippocampal neurogenesis and induces antidepressant-like effects","volume":"6","author":"Mahar","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib42","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.109.156729","article-title":"Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling","volume":"331","author":"Masood","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(94)90767-6","article-title":"Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice","volume":"666","author":"Mucke","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)64573-7","article-title":"Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease","volume":"157","author":"Mukaetova-Ladinska","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib45","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1523\/JNEUROSCI.1796-04.2004","article-title":"The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging","volume":"24","author":"Navakkode","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib46","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1523\/JNEUROSCI.2443-05.2005","article-title":"Mitogen-activated protein kinase-mediated reinforcement of hippocampal early long-term depression by the type IV-specific phosphodiesterase inhibitor rolipram and its effect on synaptic tagging","volume":"25","author":"Navakkode","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib47","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbr.2009.01.039","article-title":"Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"201","author":"O'Leary","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.nbd.2004.08.003","article-title":"Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease","volume":"17","author":"Pedersen","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\u201cBehavioural despair\u201d in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2010.01.013","article-title":"Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF","volume":"38","author":"Puerta","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib52","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1523\/JNEUROSCI.5291-04.2005","article-title":"Amyloid-beta peptide inhibits activation of the nitric oxide\/cGMP\/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity","volume":"25","author":"Puzzo","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib53","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1523\/JNEUROSCI.0864-09.2009","article-title":"Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model","volume":"29","author":"Puzzo","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib54","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1474-9726.2008.00434.x","article-title":"Selective induction of calcineurin activity and signaling by oligomeric amyloid beta","volume":"7","author":"Reese","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1601-183X.2006.00221.x","article-title":"Impaired spatial learning in the APPSwe\u00a0+\u00a0PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease","volume":"6","author":"Reiserer","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib56","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-008-1273-x","article-title":"Selective phosphodiesterase inhibitors: a promising target for cognition enhancement","volume":"202","author":"Reneerkens","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2012.02.008","article-title":"Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: indications for central and peripheral mechanisms","author":"Reneerkens","year":"2012","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib58","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1111\/j.1460-9568.2007.05589.x","article-title":"Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains","volume":"25","author":"Reyes-Irisarri","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0028-3908(98)00190-7","article-title":"Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret","volume":"38","author":"Robichaud","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bjp.0704457","article-title":"Assessing the emetic potential of PDE4 inhibitors in rats","volume":"135","author":"Robichaud","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib61","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.neuropharm.2011.08.008","article-title":"Selective phosphodiesterase inhibitors improve performance on the ED\/ID cognitive task in rats","volume":"62","author":"Rodefer","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2006.11.041","article-title":"Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors","volume":"558","author":"Rutten","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib91","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9440(10)62963-X","article-title":"Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL\/PS1M146L transgenic mice","volume":"167","author":"Rutten","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib63","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/npp.2009.24","article-title":"Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats","volume":"34","author":"Rutten","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib64","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3109\/00207454.2010.520381","article-title":"Phosphodiesterase-5 inhibitors: novel weapons against Alzheimer's disease?","volume":"120","author":"Sabayan","year":"2010","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib65","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.nbd.2004.10.022","article-title":"Episodic-like memory deficits in the APPswe\/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities","volume":"18","author":"Savonenko","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib66","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neurobiolaging.2003.08.002","article-title":"Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies","volume":"24","author":"Scheff","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib67","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2011.11.009","article-title":"Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics","volume":"83","author":"Scott Bitner","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02244871","article-title":"Behavioural and pharmacological characterisation of the elevated \u201czero-maze\u201d as an animal model of anxiety","volume":"116","author":"Shepherd","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib69","doi-asserted-by":"crossref","unstructured":"Sierksma, A. S., Prickaerts, J., Delbroek, L., Chouliaras, L., Rutten, K., Steinbusch, H., Van den Hove, D. Behavioral and neurobiological effects of prenatal stress exposure in male and female APPswe\/PS1dE9 mice Neurobiol. Aging accepted for publication.","DOI":"10.1016\/j.neurobiolaging.2012.05.012"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib70","doi-asserted-by":"crossref","first-page":"16877","DOI":"10.1073\/pnas.0908706106","article-title":"Reversal of long-term dendritic spine alterations in Alzheimer disease models","volume":"106","author":"Smith","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib71","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.expneurol.2008.02.006","article-title":"A\u00a0combined behavioral and morphological study on the effects of fetal asphyxia on the nigrostriatal dopaminergic system in adult rats","volume":"211","author":"Strackx","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib72","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nbd.2004.04.010","article-title":"Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1","volume":"16","author":"Szapacs","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib73","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib74","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.1074\/jbc.M010450200","article-title":"Beta-amyloid-(1\u201342) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised","volume":"276","author":"Tong","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib75","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neurobiolaging.2003.09.004","article-title":"Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease","volume":"25","author":"Touma","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2005.08.060","article-title":"Prenatal stress and neonatal rat brain development","volume":"137","author":"Van den Hove","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib77","doi-asserted-by":"crossref","first-page":"e22715","DOI":"10.1371\/journal.pone.0022715","article-title":"Differential effects of prenatal stress in 5-Htt deficient mice: towards molecular mechanisms of gene\u00a0\u00d7\u00a0environment interactions","volume":"6","author":"Van den Hove","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2008.10.027","article-title":"Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion","volume":"600","author":"van Donkelaar","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib79","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.neurobiolaging.2009.07.005","article-title":"Liver X receptor activation restores memory in aged AD mice without reducing amyloid","volume":"32","author":"Vanmierlo","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib80","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/eje.0.1430279","article-title":"Role of phosphodiesterase and protein kinase G on nitric oxide-induced inhibition of prolactin release from the rat anterior pituitary","volume":"143","author":"Velardez","year":"2000","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib81","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S1355617708080612","article-title":"Not all repetition is alike: different benefits of repetition in amnesia and normal memory","volume":"14","author":"Verfaellie","year":"2008","journal-title":"J.\u00a0Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib82","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1073\/pnas.172504199","article-title":"Amyloid beta -peptide inhibition of the PKA\/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling","volume":"99","author":"Vitolo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib83","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in\u00a0vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib84","first-page":"1","article-title":"The phosphodiesterase-4 inhibitor rolipram reverses Abeta-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats","author":"Wang","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib85","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0006-3223(97)00165-0","article-title":"Cortisol secretion and Alzheimer's disease progression","volume":"42","author":"Weiner","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib86","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.neurobiolaging.2008.01.009","article-title":"Synaptic contact number and size in stratum radiatum CA1 of APP\/PS1DeltaE9 transgenic mice","volume":"30","author":"West","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib87","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1532-5415.1996.tb00912.x","article-title":"Weight change in Alzheimer's disease","volume":"44","author":"White","year":"1996","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib88","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0168-0102(95)01020-3","article-title":"Reduction in the number of NADPH-diaphorase-positive cells in the cerebral cortex and striatum in aged rats","volume":"24","author":"Yamada","year":"1996","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.06.048_bib89","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0925-4439(00)00083-1","article-title":"Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease","volume":"1535","author":"Yamamoto","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.06.048_bib90","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0006-8993(99)01220-2","article-title":"Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type","volume":"824","author":"Yamamoto-Sasaki","year":"1999","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:19:43Z","timestamp":1714115983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812003061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":91,"alternative-id":["S0028390812003061"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.048","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}